1. Home
  2. ANL vs CATO Comparison

ANL vs CATO Comparison

Compare ANL & CATO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANL
  • CATO
  • Stock Information
  • Founded
  • ANL 2004
  • CATO 1946
  • Country
  • ANL Cayman Islands
  • CATO United States
  • Employees
  • ANL N/A
  • CATO N/A
  • Industry
  • ANL
  • CATO Clothing/Shoe/Accessory Stores
  • Sector
  • ANL
  • CATO Consumer Discretionary
  • Exchange
  • ANL Nasdaq
  • CATO Nasdaq
  • Market Cap
  • ANL 61.8M
  • CATO 57.6M
  • IPO Year
  • ANL 2023
  • CATO N/A
  • Fundamental
  • Price
  • ANL $1.79
  • CATO $4.63
  • Analyst Decision
  • ANL Hold
  • CATO
  • Analyst Count
  • ANL 1
  • CATO 0
  • Target Price
  • ANL N/A
  • CATO N/A
  • AVG Volume (30 Days)
  • ANL 9.3K
  • CATO 204.6K
  • Earning Date
  • ANL 09-26-2025
  • CATO 08-21-2025
  • Dividend Yield
  • ANL N/A
  • CATO N/A
  • EPS Growth
  • ANL N/A
  • CATO N/A
  • EPS
  • ANL N/A
  • CATO N/A
  • Revenue
  • ANL N/A
  • CATO $650,830,000.00
  • Revenue This Year
  • ANL N/A
  • CATO N/A
  • Revenue Next Year
  • ANL N/A
  • CATO N/A
  • P/E Ratio
  • ANL N/A
  • CATO N/A
  • Revenue Growth
  • ANL N/A
  • CATO N/A
  • 52 Week Low
  • ANL $1.10
  • CATO $2.19
  • 52 Week High
  • ANL $3.89
  • CATO $6.70
  • Technical
  • Relative Strength Index (RSI)
  • ANL 60.57
  • CATO 68.52
  • Support Level
  • ANL $1.65
  • CATO $3.84
  • Resistance Level
  • ANL $1.88
  • CATO $4.73
  • Average True Range (ATR)
  • ANL 0.10
  • CATO 0.26
  • MACD
  • ANL 0.00
  • CATO 0.01
  • Stochastic Oscillator
  • ANL 58.02
  • CATO 72.69

About ANL Adlai Nortye Ltd.

Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.

About CATO Cato Corporation (The)

The Cato Corp operates as a specialty retailer of fashion apparel and accessories in the southeastern United States. Its primary objective is to be the fashion specialty retailer for fashion and value in its markets. The company operates through the following business segments: Retail and Credit. The Retail segment which generates the majority of revenue offers fashion specialty stores. The Credit segment involves credit card services.

Share on Social Networks: